ArcheMedX
ArcheMedX is a healthcare informatics company that builds the Ready Platform, a behavioral science-based training and predictive analytics solution for clinical trial site readiness, serving pharmaceutical sponsors, biotechs, CROs, and medical education organizations.
- Company typePrivate
- Founded2019
- HeadquartersCharlottesville, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What ArcheMedX does
ArcheMedX is a privately held healthcare informatics and e-learning technology company headquartered in Charlottesville, Virginia, founded in 2013 by Joel Selzer and Brian McGowan. The company builds the Ready Platform, a behavioral science-based training and predictive analytics solution that helps pharmaceutical sponsors, biotechs, and clinical research organizations (CROs) accelerate clinical trial site activation, validate site and study team readiness, and reduce protocol deviations. Underlying the Ready Platform is the Intelligent Learning Platform, which delivers personalized content, engagement tracking, and behavioral data capture, integrating with learning and quality management systems via SAML and xAPI.
The company's core technical differentiation is its Confidence-Based Assessment (CBA) methodology and a predictive readiness engine that has modeled over 70 million behavioral data points from 5 million+ question responses generated by more than 400,000 CNS-treating clinicians. This dataset feeds the industry's first predictive readiness measure, used to inform operational decisions such as site activation, enrollment acceleration, and risk mitigation. Documented outcomes include a 90% reduction in Site Initiation Visit time, 96% of users reporting better preparedness to screen and enroll patients, 100% customer renewal and expansion, and cost savings of $350K+ in Phase 2 studies and approximately $2.5M in a global Phase 3 trial.
ArcheMedX operates a direct enterprise SaaS sales motion targeting clinical operations leaders, training heads, and study managers at top pharmaceutical companies (21 of the top 25), global CROs (top five plus mid-sized), and emerging biotechs, with additional go-to-market focus on life sciences commercial teams and medical education providers. Pricing is quote-based enterprise licensing with no publicly disclosed tiers. The company is remote-first with 11-50 employees, has raised approximately $3.7M in disclosed venture funding across 2017 and 2021, and serves clinical professionals in over 90 countries.
ArcheMedX firmographics
Firmographics- Name
- ArcheMedX
- Legal name
- ArcheMedX, Inc.
- Website
- https://archemedx.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ArcheMedX is a healthcare informatics company that builds the Ready Platform, a behavioral science-based training and predictive analytics solution for clinical trial site readiness, serving pharmaceutical sponsors, biotechs, CROs, and medical education organizations.
- Ownership category
- akta.pro rank
ArcheMedX industry classification
Industry- Product category
- Clinical Trial Readiness Software
- NAICS
- Computer Systems Design Services (541512)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industry
- Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ)
Keywords
Where ArcheMedX is headquartered
LocationHeadquarters
- HQ city
- Charlottesville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
ArcheMedX business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Revenue model
- Ready Platform SaaS/Subscription: Behavioral science-based training and predictive analytics platform licensed to pharmaceutical sponsors, biotechs, and CROs. Platform subscription likely structured as enterprise licensing with per-study or per-user pricing. 100% customer renewal and expansion rate indicates strong recurring revenue retention.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels7 records
ArcheMedX product offering
Product offeringCore offering
ArcheMedX develops and licenses the Ready Platform, a behavioral science-based training and predictive analytics SaaS that helps pharmaceutical sponsors, biotechs, and CROs accelerate clinical trial site activation, validate site and team readiness, and reduce protocol deviations. The platform delivers role-specific study training, Confidence-Based Assessments, and predictive readiness modeling built on more than 70 million behavioral data points to inform operational decisions across the clinical study lifecycle.
Product overview
ArcheMedX offers a unified product portfolio centered on the Ready Platform, a behavioral science-based training and analytics solution for clinical trials. The platform operates across three segments: Clinical Operations (for CROs and trial sponsors), Commercial Teams (for life sciences commercialization), and Medical Education. Underlying the Ready Platform is the Intelligent Learning Platform, which provides the technical capabilities for personalized learning, behavioral data capture, and predictive analytics. The Ready Platform is the primary branded product delivering study training, readiness assessment, and performance prediction, while the Intelligent Learning Platform serves as the technology foundation powering the experience.
Differentiator
Problem solved
Functional benefit
Brands
- Ready: A behavioral science-based training and predictive analytics platform designed to improve clinical trial site and study team performance. Ready delivers on-demand training, assesses readiness, and provides predictive insights for operational decisions.
Products and services
- Ready Platform Behavioral science-based training and predictive analytics SaaS that improves clinical trial site and study team performance by identifying risks sooner, delivering on-demand role-specific training, and providing predictive readiness insights to accelerate enrollment and reduce protocol deviations for pharmaceutical sponsors, biotechs, and CROs.
- Intelligent Learning Platform Underlying technology platform that powers personalized content delivery, engagement tracking, behavioral analytics, and seamless integration via SAML and xAPI standards; sold as a standalone offering to medical education companies, academic health systems, and CME providers.
Quantifiable outcome
- 90% reduction in Site Initiation Visit time across Phase 2 and Phase 3 studies (from 4+ hours to 30 minutes)
- +6 more outcomes
Companies that use ArcheMedX
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles4 records
ArcheMedX technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature5 records
ArcheMedX partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered notable and core.
- Academy of Continued Healthcare Learning (ACHL)notableAward collaboration partner on NAMEC 2017 Best Practices award for NSCLC educational initiative. ACHL collaborated with ArcheMedX, Pro-ficiency, and Simumetrix on innovative CME programming.
- Pro-ficiencynotableAward collaboration partner on NAMEC 2017 Best Practices award for NSCLC educational initiative. Collaboration focused on innovative approaches to clinician education.
- SimumetrixnotableAward collaboration partner on NAMEC 2017 Best Practices award for NSCLC educational initiative. Joint work demonstrated innovative collaboration among CME stakeholders.
- University of Virginia Health SystemnotableDevelopment partner on ACEhp 2015 Outstanding Innovation award-winning 'Flipping the Classroom' initiative. University partnership enabled data-driven nursing education innovation.
- American Nurses Credentialing CenternotableDevelopment partner on ACEhp 2015 Outstanding Innovation award-winning nursing education initiative. Partnership enabled innovation in continuing nursing education through the ArcheViewer platform.
- National Committee for Quality Assurance (NCQA)notableAward collaboration partner on 2016 Best in Class for Educational Outcomes award for PCMH program. Partnership recognized for driving quality improvement through education.
- Med-IQnotableAward collaboration partner on 2016 Best in Class for Educational Outcomes award. Joint work on PCMH program demonstrated effectiveness of collaborative educational approaches.
- University of Nebraska Medical CenternotableAward collaboration partner on NAMEC 2015 Best Practices award for CME stakeholder collaboration. Partnership included Center for Continuing Education and College of Nursing.
- ImedexnotableAward collaboration partner on NAMEC 2015 Best Practices award. Collaboration focused on online CME-certified educational activities for healthcare professionals.
- Top 25 Pharmaceutical Companies (21 of 25)core21 of the top 25 pharmaceutical firms rely on Ready platform for clinical trial training and readiness assessment. These enterprise partnerships represent core customer base driving platform development.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
ArcheMedX competitors and assessment
Company assessmentDirect peers
- Pro-ficiency: Pro-ficiency provides clinical trial simulation and readiness training to sponsors and CROs, directly overlapping with ArcheMedX's Ready platform on protocol training, SIV preparation, and site performance prediction.
- Simumetrix: Simumetrix offers web-based clinical trial simulation and competency assessment tools for sponsors and CROs, directly competing with Ready on investigator and site readiness enablement.
- Signant Health: Signant (formerly CRF Health and Bracket) provides eCOA, ePRO, rater training, and clinical trial technology — directly overlapping with ArcheMedX on site personnel training and readiness in CNS and other therapeutic areas.
Broad incumbents
- Veeva Systems: Veeva's Vault Clinical Suite (CTMS, eTMF, ePRO) is the dominant enterprise platform in clinical operations. While not focused on behavioral readiness, Veeva could bundle comparable site enablement capabilities at scale.
- Medidata Solutions (Dassault Systèmes): Medidata's Rave clinical cloud powers many of the world's largest trials with EDC, CTMS, and analytics. Its installed base and data scale position it as a long-term competitive threat to ArcheMedX's readiness analytics.
- Clario: Clario delivers eCOA, imaging, and endpoint technology for clinical trials, with a strong presence in CNS trials. As a broad incumbent, it competes for the same sponsor budget and site activation workflow as ArcheMedX.
- Oracle Health Sciences: Oracle's Clinical One and broader Health Sciences portfolio provide EDC, CTMS, and analytics to top pharma. It is a broad incumbent that could integrate comparable readiness and training capabilities into its enterprise stack.
Emerging players
- Suvoda: Suvoda provides eCOA, IRT, and eConsent technology for clinical trials, increasingly serving CNS and oncology studies that overlap with ArcheMedX's therapeutic areas of focus.
- YPrime: YPrime offers eCOA, IRT, and clinical supply chain technology for mid-sized and emerging biotech sponsors — a customer segment that overlaps with ArcheMedX's growing biotech book of business.
- Medable: Medable is a leading decentralized clinical trial (DCT) platform serving top pharma, intersecting with ArcheMedX's site enablement and readiness thesis as trials become more decentralized and site training needs evolve.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
ArcheMedX social profiles
Digital presenceArcheMedX compliance and trust
Trust signalCompliance2 records
ArcheMedX financial estimates
Financial estimateRevenue estimate
Valuation estimate
ArcheMedX leadership team
Management profileNumber of profiles
Profiles7 records
ArcheMedX funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ArcheMedX M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ArcheMedX
What does ArcheMedX do?
ArcheMedX develops and licenses the Ready Platform, a behavioral science-based training and predictive analytics SaaS that helps pharmaceutical sponsors, biotechs, and CROs accelerate clinical trial site activation, validate site and team readiness, and reduce protocol deviations. The platform delivers role-specific study training, Confidence-Based Assessments, and predictive readiness modeling built on more than 70 million behavioral data points to inform operational decisions across the clinical study lifecycle.
Is ArcheMedX a public or private company?
ArcheMedX is a private company. It is classified as venture growth investor backed and is currently operating.
When was ArcheMedX founded?
ArcheMedX was founded in 2019. It employs 11 to 50 people.
Where is ArcheMedX based?
ArcheMedX is headquartered in Charlottesville, United States, in the North America region.
How does ArcheMedX make money?
One revenue line is on record: ready Platform SaaS/Subscription.
Who are ArcheMedX's main competitors?
Direct peers on record are Pro-ficiency, Simumetrix and Signant Health. Broad incumbents are Veeva Systems, Medidata Solutions (Dassault Systèmes), Clario and Oracle Health Sciences. Emerging players are Suvoda, YPrime and Medable.
Does ArcheMedX have an API?
No public API is recorded for ArcheMedX.
What industry is ArcheMedX in?
ArcheMedX's product category is Clinical Trial Readiness Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation). Its NAICS code is 541512 and its SIC code is 7372.